GMED Globus Medical, Inc. Class A Common Stock

NYSE · Health Care · View on SEC EDGAR ↗
$88.24
Price · Aug 19, 2026
Fundamentals as of Aug 6, 2026

About Globus Medical, Inc. Class A Common Stock Company overview from Wikipedia

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Read more

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Products

Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.

Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.

The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.

Acquisitions

In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.

In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.

In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.

In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.

In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.

In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.

Controversies

In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.

In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

GMED Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$88.24
Market Cap
P/E (TTM)
22.3
EPS (TTM)
$3.92
Revenue (TTM)
$2.94B
Div Yield
ROE
12.1%
Debt/Equity
52W Range
$54 – $101

GMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $2.94B
10-point trend, +421.1%
2016-12-31 2025-12-31
EPS $3.92
10-point trend, +263.0%
2016-12-31 2025-12-31
Free Cash Flow $589M
9-point trend, +349.5%
2016-12-31 2025-12-31
Margins 18.3%
7-point trend, -14.5%
2016-12-31 2023-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
GMED
Peer Median
P/E (TTM)
5-point trend, -55.6%
22.3
27.5

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
GMED
Peer Median
Operating Margin
5-point trend, +15.7%
16.3%
Net Profit Margin
5-point trend, +41.2%
18.3%
9.8%
ROA
5-point trend, +60.0%
10.2%
5.1%
ROE
5-point trend, +73.3%
12.1%
8.6%
ROIC
5-point trend, +55.2%
9.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
GMED
Peer Median
Current Ratio
5-point trend, -37.3%
4.3
2.7
Quick Ratio
5-point trend, +111.4%
2.5

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
GMED
Peer Median
Revenue YoY
5-point trend, +206.7%
16.7%
Revenue CAGR 3Y
5-point trend, +206.7%
42.2%
Revenue CAGR 5Y
5-point trend, +206.7%
30.1%
EPS YoY
5-point trend, +172.2%
422.7%
Net Income YoY
5-point trend, +260.5%
422.3%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
GMED
Peer Median
EPS (Diluted)
5-point trend, +172.2%
$3.92

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
GMED
Peer Median

GMED Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 23 analysts
  • Strong Buy 4 17.4%
  • Buy 12 52.2%
  • Hold 7 30.4%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

13 analysts · 2026-08-15
Median target $100.00 +13.3%
Mean target $103.23 +17.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.15%
Period EPS Actual EPS Est Surprise
June 30, 2026 $1.34 $1.12 0.22%
March 31, 2026 $1.12 $0.94 0.18%
Dec. 31, 2025 $1.28 $1.17 0.11%
Sept. 30, 2025 $1.18 $0.80 0.38%
June 30, 2025 $0.86 $0.77 0.09%
March 31, 2025 $0.68 $0.76 -0.08%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
GMED 22.3 16.7% 18.3% 12.1%
RMD $28.11B 18.7 9.8% 26.9% 23.6% 61.1%
ZBH $28.66B 25.3 7.2% 8.6% 5.6%
BAX $13.05B -10.2 5.7% -8.5% -14.6% 30.0%
PEN $12.20B 68.8 17.5% 12.7% 13.1% 67.1%
GKOS $6.49B -34.4 32.3% -37.0% -26.4% 55.7%
PODD $20.01B 81.7 30.7% 9.1% 16.6% 71.6%
TFX -6.0 17.2% -45.5% -24.6% 56.2%
NVST $3.56B 77.5 8.3% 1.7% 1.5% 54.7%
ITGR $2.69B 27.1 8.0% 5.5% 6.0% 27.0%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16
Annual Income Statement data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Cost of Revenue 12-point trend, +764.7% $958M $1.04B $548M $264M $239M $217M $180M $159M $150M $135M $132M $111M
Gross Profit 10-point trend, +180.6% · · $1.02B $759M $719M $572M $605M $554M $486M $429M $412M $364M
R&D Expense 12-point trend, +372.5% $147M $164M $124M $73M $97M $85M $60M $55M $44M $45M $36M $31M
SG&A Expense 12-point trend, +524.8% $1.18B $981M $644M $432M $408M $355M $355M $312M $268M $222M $210M $189M
Operating Expenses 10-point trend, +293.9% · · $887M $531M $547M $460M $433M $384M $324M $275M $240M $225M
Operating Income 12-point trend, +246.8% $480M $166M $133M $228M $172M $111M $172M $169M $162M $154M $172M $138M
Other Non-op 12-point trend, +1118.9% $3M $2M $-2M $2M $8M $14M $18M $19M $8M $3M $583.0K $280.0K
Pretax Income 12-point trend, +336.4% $605M $121M $165M $243M $180M $126M $190M $189M $170M $157M $173M $139M
Income Tax 12-point trend, +45.6% $67M $18M $43M $53M $31M $24M $35M $32M $63M $53M $60M $46M
Net Income 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
EPS (Basic) 12-point trend, +306.1% $3.98 $0.76 $1.09 $1.89 $1.48 $1.04 $1.57 $1.60 $1.12 $1.09 $1.19 $0.98
EPS (Diluted) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Shares (Basic) 12-point trend, +43.5% 135,215,000 135,726,000 113,087,000 100,469,000 100,734,000 98,580,000 99,150,000 97,884,000 96,243,000 95,647,000 95,046,000 94,227,000
Shares (Diluted) 12-point trend, +43.6% 137,056,000 137,863,000 114,630,000 102,643,000 103,623,000 100,971,000 101,998,000 101,316,000 97,887,000 96,432,000 96,073,000 95,457,000
EBITDA 11-point trend, +372.6% $757M $420M $278M · $242M $174M $225M $211M $204M $193M $196M $160M
Balance Sheet 26
Annual Balance Sheet data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 8-point trend, +539.6% $526M $784M · · · · $195M $140M $119M $67M $58M $82M
Short-term Investments 11-point trend, -78.8% $31M $106M $50M $296M $250M $187M · $200M $255M $223M $221M $146M
Receivables 12-point trend, +800.1% $679M $558M $503M $213M $164M $142M $154M $137M $117M $92M $78M $75M
Inventory 12-point trend, +734.9% $759M $659M $848M $299M $237M $229M $196M $131M $108M $113M $105M $91M
Prepaid Expense 12-point trend, +1039.4% $65M $50M $45M $21M $18M $18M $17M $15M $11M $15M $7M $6M
Current Assets 12-point trend, +352.2% $2.13B $2.18B $1.92B $983M $865M $822M $687M $631M $620M $514M $545M $470M
PP&E (Net) 12-point trend, +712.5% $564M $562M $587M $244M $221M $217M $200M $172M $143M $124M $115M $69M
PP&E (Gross) 12-point trend, +575.2% $1.27B $1.11B $1.01B $587M $527M $493M $444M $389M $335M $291M $254M $188M
Accum. Depreciation 12-point trend, +494.7% $705M $546M $426M $343M $306M $276M $244M $217M $192M $167M $139M $119M
Goodwill 12-point trend, +2597.6% $1.44B $1.43B $1.43B $197M $180M $157M $129M $124M $124M $106M $92M $53M
Intangibles 12-point trend, +2057.8% $745M $795M $925M $64M $69M $87M $79M $87M $79M $62M $33M $35M
Other Non-current Assets 12-point trend, +7980.1% $79M $75M $79M $37M $36M $32M $22M $10M $8M $928.0K $590.0K $975.0K
Total Assets 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Accounts Payable 12-point trend, +521.6% $99M $75M $57M $36M $22M $18M $25M $26M $25M $17M $16M $16M
Accrued Liabilities 12-point trend, +442.4% $334M $261M $240M $92M $91M $78M $63M $60M $53M $46M $54M $61M
Current Liabilities 12-point trend, +457.5% $498M $856M $392M $159M $140M $121M $111M $96M $93M $80M $83M $89M
Capital Leases 7-point trend, +8999.6% $104M $84M $91M $3M $3M $3M $1M · · · · ·
Deferred Tax 11-point trend, +362.4% · $24M $84M $2M $4M $6M $6M $8M $11M $8M $13M $5M
Other Non-current Liabilities 12-point trend, +542.9% $21M $22M $25M $10M $13M $15M $9M $8M $2M $2M $2M $3M
Total Liabilities 12-point trend, +517.7% $730M $1.07B $1.09B $230M $216M $173M $130M $115M $111M $96M $119M $118M
Paid-in Capital 12-point trend, +1708.8% $3.17B $3.03B $2.87B $631M $554M $457M $357M $300M $238M $212M $193M $175M
Retained Earnings 12-point trend, +237.1% $1.39B $1.15B $1.14B $1.24B $1.19B $1.05B $1.05B $893M $736M $629M $525M $412M
AOCI 12-point trend, +1026.1% $15M $-7M $-10M $-25M $-7M $4M $-3M $-7M $-7M $-9M $-2M $-2M
Stockholders' Equity 12-point trend, +681.1% $4.57B $4.18B $4.00B $1.85B $1.74B $1.51B $1.40B $1.19B $968M $832M $715M $585M
Liabilities + Equity 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Shares Outstanding 6-point trend, +5.4% · · · · · · 99,825,080 98,573,354 96,657,881 95,929,916 95,319,722 94,705,743
Cash Flow 16
Annual Cash Flow data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +1172.6% $277M $253M $146M $68M $70M $63M $53M $42M $42M $39M $24M $22M
Stock-based Comp 12-point trend, +600.0% $50M $54M $53M $33M $31M $27M $26M $22M $15M $11M $10M $7M
Deferred Tax 11-point trend, -3234.3% · $-134M $-58M $-22M $-18M $-4M $4M $971.0K $8M $-4M $6M $-4M
Amort. of Intangibles 12-point trend, +16500.3% $118M $119M $51M $18M $19M $17M $14M $10M $8M $3M $2M $712.0K
Restructuring · $30M · · · · · · · · · ·
Other Non-cash 11-point trend, -191.0% $-111M $243M $-19M · $44M $11M $-66M $-39M $-13M $22M $-31M $-38M
Operating Cash Flow 12-point trend, +851.7% $753M $521M $243M $178M $276M $199M $172M $182M $159M $148M $124M $79M
CapEx 12-point trend, +565.3% $165M $115M $78M $74M $57M $64M $71M $60M $51M $41M $51M $25M
Investing Cash Flow 12-point trend, -255.0% $-355M $-176M $303M $-110M $-376M $-117M $-140M $-193M $-111M $-163M $-153M $-100M
Stock Issued · · · · · · · · · · · $10M
Stock Repurchased 5-point trend, +187.0% $300M $86M $226M $144M · $105M · · · · · ·
Net Stock Activity 5-point trend, -3185.3% $-300M $-86M $-226M · · $-105M · · · · · $10M
Financing Cash Flow 12-point trend, -5346.1% $-679M $-28M $-232M $-110M $54M $-39M $24M $33M $2M $470.0K $4M $13M
Net Change in Cash 12-point trend, -3255.6% $-258M $317M $317M $-43M $-46M $44M $56M $21M $51M $-16M $-25M $-8M
Taxes Paid 8-point trend, +223.8% $99M $159M $101M $78M $45M $25M $34M $31M · · · ·
Free Cash Flow 11-point trend, +981.9% $589M $405M $165M · $219M $135M $101M $122M $108M $131M $71M $54M
Profitability 8
Annual Profitability data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 9-point trend, -15.1% · · 65.0% · 75.0% 72.4% 77.1% 77.6% 76.3% 76.1% 75.6% 76.6%
Operating Margin 11-point trend, -44.0% 16.3% 6.6% 8.5% · 17.9% 14.1% 21.9% 23.8% 25.4% 27.3% 31.6% 29.2%
Net Margin 11-point trend, -6.2% 18.3% 4.1% 7.8% · 15.6% 13.0% 19.8% 21.9% 16.9% 18.5% 20.7% 19.5%
Pretax Margin 11-point trend, -29.6% 20.6% 4.8% 10.5% · 18.8% 16.0% 24.2% 26.5% 26.7% 27.9% 31.7% 29.2%
EBITDA Margin 11-point trend, -23.7% 25.8% 16.7% 17.7% · 25.2% 22.1% 28.6% 29.6% 32.1% 34.2% 36.0% 33.8%
ROA 11-point trend, -30.1% 10.2% 2.0% 3.4% · 8.2% 6.4% 11.0% 13.2% 10.7% 11.8% 14.7% 14.6%
ROE 11-point trend, -30.6% 12.1% 2.5% 3.0% · 8.6% 7.0% 11.3% 13.5% 11.9% 13.5% 17.3% 17.5%
ROIC 11-point trend, -40.8% 9.3% 3.4% 2.5% · 8.2% 6.0% 10.0% 11.8% 10.6% 12.3% 15.7% 15.8%
Liquidity & Solvency 2
Annual Liquidity & Solvency data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -18.9% 4.3 2.5 4.9 · 6.2 6.8 6.2 6.6 6.7 6.4 6.6 5.3
Quick Ratio 11-point trend, -27.1% 2.5 0.8 1.4 · 3.0 1.2 3.1 5.0 5.3 4.8 4.3 3.4
Efficiency 3
Annual Efficiency data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -25.5% 0.6 0.5 0.4 · 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7
Inventory Turnover 11-point trend, -1.8% 1.4 1.4 1.0 · 1.0 1.0 1.1 1.3 1.4 1.2 1.4 1.4
Receivables Turnover 11-point trend, -30.9% 4.8 4.7 4.4 · 6.3 5.3 5.4 5.6 6.1 6.6 7.1 6.9
Per Share 5
Annual Per Share data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 6-point trend, +127.3% · · · · · · $14.05 $12.03 $10.01 $8.67 $7.50 $6.18
Revenue / Share 11-point trend, +331.5% $21.44 $18.27 $13.68 · $9.25 $7.81 $7.70 $7.04 $6.50 $5.85 $5.67 $4.97
Cash Flow / Share 11-point trend, +562.8% $5.50 $3.78 $2.12 · $2.67 $1.97 $1.69 $1.79 $1.63 $1.78 $1.27 $0.83
Cash / Share 6-point trend, +125.4% · · · · · · $1.96 $1.42 $1.23 $1.38 $0.63 $0.87
EPS (TTM) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Growth Rates 9
Annual Growth Rates data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -22.3% 16.7% 60.6% 53.3% 6.8% 21.4% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +63.8% 42.2% 38.0% 25.7% · · · · · · · · ·
Revenue CAGR 5Y 30.1% · · · · · · · · · · ·
EPS YoY 5-point trend, +892.9% 422.7% -29.9% -42.2% 28.5% 42.6% · · · · · · ·
EPS CAGR 3Y 3-point trend, +1366.0% 28.4% -19.5% 1.9% · · · · · · · · ·
EPS CAGR 5Y 31.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +820.8% 422.3% -16.2% -35.4% 27.5% 45.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +557.5% 41.4% -11.6% 6.3% · · · · · · · · ·
Net Income CAGR 5Y 39.4% · · · · · · · · · · ·
Valuation (TTM) 9
Annual Valuation (TTM) data for GMED
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Net Income TTM 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
Market Cap 6-point trend, +161.1% · · · · · · $5.88B $4.27B $3.97B $2.38B $2.65B $2.25B
P/E 12-point trend, -9.1% 22.3 110.3 49.8 40.1 50.1 64.6 38.7 28.1 37.4 23.0 23.8 24.5
P/S 6-point trend, +57.7% · · · · · · 7.5 6.0 6.2 4.2 4.9 4.7
P/B 6-point trend, +9.0% · · · · · · 4.2 3.6 4.1 2.9 3.7 3.8
P / Cash Flow 6-point trend, +20.2% · · · · · · 34.2 23.5 24.9 13.8 21.7 28.4
P / FCF 6-point trend, +40.4% · · · · · · 58.1 35.0 36.7 18.2 37.2 41.4
Earnings Yield 12-point trend, +10.0% 4.5% 0.91% 2.0% 2.5% 2.0% 1.6% 2.6% 3.6% 2.7% 4.3% 4.2% 4.1%

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $2.94B$2.52B$1.57B$1.02B$958M
Gross Margin % 65.0%75.0%
Operating Margin % 16.3%6.6%8.5%17.9%
Net Income $538M$103M$123M$190M$149M
Diluted EPS $3.92$0.75$1.07$1.85$1.44
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 4.32.54.96.2
Quick Ratio 2.50.81.43.0
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $589M$405M$165M$219M

Trading Signals Recent buy/sell signals with entry price and risk/reward ratio

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 642 filers · $5.7B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
82 (-27 vs prior Q) 80 (+30 vs prior Q) 241 (+22 vs prior Q) 176 (-6 vs prior Q) +11.4M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD CAPITAL MANAGEMENT LLC $403,546,103 5,107,532 7.04% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $394,606,359 4,994,385 6.89% Shares
STATE STREET CORP $293,540,630 3,714,029 5.12% Shares
Sculptor Capital LP $237,030,000 3,000,000 4.14% Shares
Burgundy Asset Management Ltd. $212,054,428 3,460,983 3.70% Shares
ALLIANCEBERNSTEIN L.P. $205,090,439 2,380,344 3.58% Shares
DIMENSIONAL FUND ADVISORS LP $166,610,599 2,108,728 2.91% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $135,630,225 1,716,621 2.37% Shares
GEODE CAPITAL MANAGEMENT, LLC $134,690,079 1,704,191 2.35% Shares
Boston Partners $112,054,767 1,418,394 1.96% Shares
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC $101,519,633 1,284,896 1.77% Shares
Quantinno Capital Management LP $96,320,933 1,219,098 1.68% Shares
NORGES BANK $89,048,300 1,127,051 1.55% Shares
FULLER & THALER ASSET MANAGEMENT, INC. $88,055,393 1,114,484 1.54% Shares
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $88,048,981 1,114,403 1.54% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $84,736,329 1,072,476 1.48% Shares
GENEVA CAPITAL MANAGEMENT LLC $78,941,870 999,138 1.38% Shares
Madison Avenue Partners, LP $73,891,416 935,216 1.29% Shares
Boston Trust Walden Corp $73,637,557 932,003 1.28% Shares
ANTIPODES PARTNERS Ltd $71,581,796 905,984 1.25% Shares
Global Alpha Capital Management Ltd. $67,681,230 856,616 1.18% Shares
Vestal Point Capital, LP $67,158,500 850,000 1.17% Shares
VANGUARD GROUP INC $59,221,500 678,290 1.03% Shares
Stephens Investment Management Group LLC $57,159,864 723,451 1.00% Shares
VANGUARD FIDUCIARY TRUST CO $56,575,822 716,059 0.99% Shares
Clark Capital Management Group, Inc. $54,271,890 686,899 0.95% Shares
AMERICAN CAPITAL MANAGEMENT INC $51,599,219 653,072 0.90% Shares
ANCHOR CAPITAL ADVISORS LLC $51,225,201 648,338 0.89% Shares
Camber Capital Management LP $47,216,000 800,000 0.82% Shares
Capital World Investors $46,664,254 590,612 0.81% Shares
Artemis Investment Management LLP $45,305,914 573,420 0.79% Shares
Swedbank AB $41,113,881 520,363 0.72% Shares
OBERWEIS ASSET MANAGEMENT INC/ $40,461,021 512,100 0.71% Shares
RAYMOND JAMES FINANCIAL INC $39,194,096 496,065 0.68% Shares
Paradice Investment Management LLC $39,023,513 493,906 0.68% Shares
Soleus Capital Management, L.P. $37,049,527 468,922 0.65% Shares
VICTORY CAPITAL MANAGEMENT INC $34,953,155 442,389 0.61% Shares
ENVESTNET ASSET MANAGEMENT INC $34,559,104 437,402 0.60% Shares
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ $33,569,453 424,876 0.59% Shares
FIRST TRUST ADVISORS LP $32,942,568 416,943 0.57% Shares
FMR LLC $32,503,608 411,386 0.57% Shares
Grantham, Mayo, Van Otterloo & Co. LLC $32,370,792 409,705 0.56% Shares
Holocene Advisors, LP $31,598,627 399,932 0.55% Shares
Pembroke Management, LTD $31,513,929 398,860 0.55% Shares
GOLDMAN SACHS GROUP INC $31,286,538 395,982 0.55% Shares
Annex Advisory Services, LLC $30,189,344 350,387 0.53% Shares
Bares Capital Management, Inc. $29,845,058 521,129 0.52% Shares
Capital Impact Advisors, LLC $29,246,895 370,167 0.51% Shares
SIRIOS CAPITAL MANAGEMENT L P $28,050,051 355,019 0.49% Shares
Bridgewater Associates, LP $27,809,466 351,974 0.49% Shares
CONGRESS ASSET MANAGEMENT CO $26,754,761 338,625 0.47% Shares
Terril Brothers, Inc. $25,403,295 321,520 0.44% Shares
Sio Capital Management, LLC $23,846,482 301,816 0.42% Shares
SEGALL BRYANT & HAMILL, LLC $23,729,389 300,334 0.41% Shares
Champlain Investment Partners, LLC $22,982,271 290,878 0.40% Shares
RHUMBLINE ADVISERS $22,513,223 284,942 0.39% Shares
Gotham Asset Management, LLC $22,364,413 283,058 0.39% Shares
UBS Group AG $22,286,430 282,071 0.39% Shares
KENNEDY CAPITAL MANAGEMENT LLC $22,020,640 278,707 0.38% Shares
MetLife Investment Management, LLC $21,771,680 275,556 0.38% Shares
Kathmere Capital Management, LLC $21,450,978 271,497 0.37% Shares
Retirement Systems of Alabama $20,830,354 263,642 0.36% Shares
Foresight Group Ltd Liability Partnership $19,759,724 254,030 0.34% Shares
NICHOLAS COMPANY, INC. $19,699,484 249,329 0.34% Shares
BANK OF AMERICA CORP /DE/ $19,524,872 247,119 0.34% Shares
Varenne Capital Partners $18,807,009 238,200 0.33% Shares
GLENMEDE TRUST CO NA $18,639,881 235,918 0.33% Shares
Mesirow Institutional Investment Management, Inc. $18,549,041 224,266 0.32% Shares
California Public Employees Retirement System $18,120,944 229,350 0.32% Shares
Woodline Partners LP $17,906,826 226,640 0.31% Shares
Swiss National Bank $17,862,344 226,077 0.31% Shares
Corient Private Wealth LP $17,322,828 219,248 0.30% Shares
GABELLI FUNDS LLC $16,671,110 211,000 0.29% Shares
Lightrock Netherlands B.V. $16,367,000 207,151 0.29% Shares
Sofinnova Investments, Inc. $15,802,000 200,000 0.28% Call option
RENAISSANCE TECHNOLOGIES LLC $15,558,491 196,918 0.27% Shares
STATE OF WISCONSIN INVESTMENT BOARD $15,455,225 195,611 0.27% Shares
LPL Financial LLC $15,233,500 192,805 0.27% Shares
Susquehanna Portfolio Strategies, LLC $15,165,574 191,945 0.26% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $14,032,018 177,598 0.24% Shares
Leith Wheeler Investment Counsel Ltd. $13,821,540 174,934 0.24% Shares
BlackRock, Inc. $13,638,706 172,620 0.24% Shares
AMERICAN CENTURY COMPANIES INC $13,486,770 170,697 0.24% Shares
WCM INVESTMENT MANAGEMENT, LLC $13,455,918 160,304 0.23% Shares
Leeward Investments, LLC - MA $12,983,476 164,327 0.23% Shares
Walleye Capital LLC $12,358,823 156,421 0.22% Shares
JANUS HENDERSON GROUP PLC $12,232,394 141,973 0.21% Shares
Bellevue Group AG $11,543,993 146,108 0.20% Shares
Sterling Investment Advisors, Ltd. $11,379,257 144,023 0.20% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $11,223,202 130,260 0.20% Shares
Defilade Capital Management, L.P. $11,032,719 139,637 0.19% Shares
PARADIGM CAPITAL MANAGEMENT INC/NY $10,934,984 138,400 0.19% Shares
Glenmede Investment Management, LP $10,909,935 190,500 0.19% Shares
BNP PARIBAS FINANCIAL MARKETS $10,809,042 136,806 0.19% Shares
ALGERT GLOBAL LLC $10,560,477 133,660 0.18% Shares
GAMCO INVESTORS, INC. ET AL $10,209,435 129,217 0.18% Shares
ArrowMark Colorado Holdings LLC $9,102,268 115,204 0.16% Shares
STRS OHIO $8,815,936 111,580 0.15% Shares
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. $8,503,609 107,627 0.15% Shares
VANGUARD ASSET MANAGEMENT, Ltd $8,430,130 106,697 0.15% Shares

Company insiders 22 insiders · 11 officers · 15 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Keith W Pfeil President, CEO Jan. 21, 2026 A 0 0 0 $0
Daniel T Scavilla President, CEO Jan. 23, 2025 A 0 0 0 $0
David M Demski President, CEO Jan. 27, 2022 A 0 0 0 $0
Kyle Kline Senior Vice President, CFO Jan. 21, 2026 A 0 0 2 $-2,032,133
Richard A Baron Senior VP and CFO May 2, 2014 M 0 0 0 $0
Anthony L Williams President March 7, 2019 M 0 0 0 $0
Kelly Huller EVP, GC, Corporate Secretary Feb. 25, 2026 M 0 0 3 $-3,441,700
David C Paul Executive Chairman Jan. 21, 2026 A 60,417 0 0 $0
Steven Payne Chief Accounting Officer Feb. 1, 2019 A 0 0 0 $0
Eric Schwartz Senior VP and General Counsel June 25, 2018 M 0 0 0 $0
Brett A Murphy EVP, International Sales Feb. 2, 2018 A 35,217 0 0 $0
David D Davidar Director July 27, 2026 G 507,675 0 2 $-4,169,000
Ann D Rhoads Director June 4, 2026 M 40,384 0 3 $-1,402,600
Dan Wolterman Director Jan. 21, 2026 A 24,025 0 0 $0
Leslie V Norwalk Director Jan. 21, 2026 A 10,419 0 2 $-557,600
Dan Lemaitre Director Jan. 21, 2026 A 0 0 0 $0
John A Deford Director Jan. 21, 2026 A 15,578 0 0 $0
Robert Andrew Douglas Director Jan. 21, 2026 A 2,005 0 0 $0
Stephen T Zarrilli Director Jan. 21, 2026 A 0 0 1 $-2,107,250
James R Tobin Director Jan. 21, 2026 A 0 0 0 $0
Kurt Wheeler Director Jan. 22, 2019 A 44,319 0 0 $0
Robert Liptak Director Jan. 22, 2019 A 26,159 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 99 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
FXH · First Trust Exchange-Traded AlphaDE… 2.27% 219,621 NS April 30, 2026 N-PORT
GRPM · Invesco Exchange-Traded Fund Trust 1.93% 118,993 SH Aug. 8, 2026 Daily
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1.86% 10,979 NS April 30, 2026 N-PORT
BUL · Pacer Funds Trust 1.53% 21,591 NS April 30, 2026 N-PORT
IHI · iShares Trust 1.30% 536,949 SH Aug. 8, 2026 Daily
LFSC · RBB Fund, Inc. 1.27% 16,258 NS May 31, 2026 N-PORT
ROBO · EXCHANGE TRADED CONCEPTS TRUST 1.24% 242,837 NS April 30, 2026 N-PORT
DTEC · ALPS ETF Trust 0.87% 7,891 NS May 31, 2026 N-PORT
TAX · EA Series Trust 0.86% 2,682 NS May 29, 2026 N-PORT
RFG · Invesco Exchange-Traded Fund Trust 0.86% 37,446 SH Aug. 8, 2026 Daily
LSEQ · Harbor ETF Trust 0.83% 1,408 NS April 30, 2026 N-PORT
MCOW · Pacer Funds Trust 0.82% 90 NS April 30, 2026 N-PORT
FNY · First Trust Exchange-Traded AlphaDE… 0.55% 31,832 NS April 30, 2026 N-PORT
TMFX · RBB Fund, Inc. 0.54% 2,130 NS May 31, 2026 N-PORT
CZA · Invesco Exchange-Traded Fund Trust 0.51% 11,913 SH Aug. 8, 2026 Daily
IJK · iShares Trust 0.49% 662,259 SH Aug. 8, 2026 Daily
IVOG · VANGUARD ADMIRAL FUNDS 0.47% 111,810 SH Aug. 8, 2026 Daily
MMSC · First Trust Exchange-Traded Fund VI… 0.39% 2,462 NS May 31, 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0.38% 18,545 NS April 30, 2026 N-PORT
GQQQ · EA Series Trust 0.34% 5,950 NS May 29, 2026 N-PORT
BKMC · BNY Mellon ETF Trust 0.31% 21,679 NS April 30, 2026 N-PORT
PTMC · Pacer Funds Trust 0.29% 12,781 NS April 30, 2026 N-PORT
XJH · iShares Trust 0.29% 15,314 SH Aug. 8, 2026 Daily
ISCG · iShares Trust 0.29% 35,610 SH Aug. 8, 2026 Daily
FNX · First Trust Exchange-Traded AlphaDE… 0.29% 42,239 NS April 30, 2026 N-PORT
SMDX · Tidal Trust III 0.29% 3,969 NS April 30, 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.28% 26,195 NS May 31, 2026 N-PORT
QVMM · Invesco Exchange-Traded Fund Trust … 0.28% 15,001 SH Aug. 8, 2026 Daily
ANEW · ProShares Trust 0.26% 244 NS May 31, 2026 N-PORT
IJH · iShares Trust 0.25% 3,909,873 SH Aug. 8, 2026 Daily
IVOO · VANGUARD ADMIRAL FUNDS 0.25% 183,180 SH Aug. 8, 2026 Daily
VBK · VANGUARD INDEX FUNDS 0.24% 1,499,816 SH Aug. 8, 2026 Daily
CLSE · Trust for Professional Managers 0.23% 17,617 NS May 31, 2026 N-PORT
BFOR · ALPS ETF Trust 0.22% 5,809 NS May 31, 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0.21% 56,008 NS April 30, 2026 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0.21% 46,648 NS April 30, 2026 N-PORT
MIDU · Direxion Shares ETF Trust 0.20% 1,845 NS April 30, 2026 N-PORT
MVV · ProShares Trust 0.20% 3,849 NS May 31, 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.19% 535,955 NS May 31, 2026 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0.17% 2,091 NS May 31, 2026 N-PORT
SCHM · SCHWAB STRATEGIC TRUST 0.17% 300,905 NS May 31, 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0.16% 8,751 NS April 30, 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.16% 51,771 NS April 30, 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0.16% 7,980 NS April 30, 2026 N-PORT
IYH · iShares Trust 0.15% 67,336 SH Aug. 8, 2026 Daily
REVS · Columbia ETF Trust I 0.15% 4,563 NS April 30, 2026 N-PORT
ISCB · iShares Trust 0.14% 5,059 SH Aug. 8, 2026 Daily
UMDD · ProShares Trust 0.14% 538 NS May 31, 2026 N-PORT
VHT · VANGUARD WORLD FUND 0.13% 338,547 SH Aug. 8, 2026 Daily
DFAS · Dimensional ETF Trust 0.13% 199,853 NS April 30, 2026 N-PORT